← Open Payments lookup

GERARDO RIVERA: Open Payments

NPI 1992399125 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$778 in 10 payments from 8 companies in 2025. Trend: 2023 $2,027 · 2024 $1,213 · 2025 $778

Food & beverage: $778
CompanyPaymentsAmount
Madrigal Pharmaceuticals2$254
ViiV Healthcare Company2$235
Gilead Sciences, Inc.1$122
AstraZeneca Pharmaceuticals LP1$74
Ferring Pharmaceuticals Inc.1$27
Janssen Biotech, Inc.1$23
Novartis Pharmaceuticals Corporation1$21
Exelixis Inc.1$21

Products named: REZDIFFRA, APRETUDE, Yeztugo, FLUMIST QUADRIVALENT, ADSTILADRIN, ERLEADA, COSENTYX, CABOMETYX.

Industry payments across TX — which companies pay providers there.